Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

> it actually turns out to be about the same or cheaper than ongoing treatment of a untreated sickle cell

If I were a betting man I'd wager the house that the above is exactly why it costs what it does. 'Pay 2 million now, or pay 2 million over the rest of the patient's life as they suffer' is a pretty inarguable value proposition.

Of course once patents expire and processes refine prices will come down. The wheel of progress rolls on (more of less) as intended.



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: